Nuvation Bio Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: Nuvation Bio Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Nuvation Bio Inc - Ordinary Shares - Class A
Rating: 2.16091675
Author: Trendlyne DVM scores

about

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-g...

3.73 0.02 (0.54%)

142.21% Gain from 52W Low

2.3M

XNYS Volume

XNYS 03 Oct, 2025 1:44 PM (EDT)

Not Eligible

Expensive Valuation

10.2 / 100

Technically Bullish

76.3 / 100

1Yr Price target upside is 119%

6 analysts

Nuvation Bio Inc Ordinary Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Nuvation Bio Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-g...

142.21% Gain from 52W Low

SWOT Analysis

Nuvation Bio Inc Ordinary Live Price Chart